PCRX
Pacira BioSciences·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
PCRX fundamentals
Pacira BioSciences (PCRX) released its earnings on Nov 6, 2025: revenue was 179.50M (YoY +6.48%), missed estimates; EPS was 0.7 (YoY -11.39%), beat estimates.
Revenue / YoY
179.50M
+6.48%
EPS / YoY
0.7
-11.39%
Report date
Nov 6, 2025
PCRX Earnings Call Summary for Q3,2025
- Revenue Growth: 6% YoY driven by 9% EXPAREL volume (highest in 3 years) and 82% gross margin
- Strategic Investments: $50M share buyback, AMT-143 licensing for 14-day analgesia, and Phase II PCRX-201 gene therapy
- Pipeline Momentum: 100M+ covered lives for EXPAREL, 3-year OA registry data showing opioid reduction, and J&J partnership accelerating Zilretta adoption
- Risk Mitigation: 21st EXPAREL patent and disciplined IP defense against generics
EPS
Revenue
Revenue & Expenses
PCRX has released its 2025 Q3 earnings report, with revenue of 179.52M, reflecting a YoY change of 6.49%, and net profit of 5.43M, showing a YoY change of 103.79%. The Sankey diagram below clearly presents PCRX's revenue sources and cost distribution.
Key Indicators
Pacira BioSciences (PCRX) key financial stats and ratios, covering profitability, financial health, and leverage.
Pacira BioSciences (PCRX)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Pacira BioSciences (PCRX)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Pacira BioSciences (PCRX)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Pacira BioSciences (PCRX) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Pacira BioSciences (PCRX) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What is Pacira BioSciences's latest dividend and current dividend yield?What is the revenue and EPS growth rate for Pacira BioSciences year over year?What were the key takeaways from Pacira BioSciences’s earnings call?What does Pacira BioSciences do and what are its main business segments?What factors drove the changes in Pacira BioSciences's revenue and profit?Did Pacira BioSciences beat or miss consensus estimates last quarter?What is the market's earnings forecast for Pacira BioSciences next quarter?What guidance did Pacira BioSciences's management provide for the next earnings period?
